- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01486654
Transcranial Direct Current Stimulation and Aphasia Language Therapy
Study Overview
Status
Conditions
Detailed Description
Stroke is the third leading cause of death and the most common cause of disability in the United States. According to the American Stroke Association, the prevalence of stroke in the U.S. is approximately 4.8 million with approximately 700,000 additional strokes occurring annually. Approximately 150,000 to 250,000 stroke survivors becoming severely and permanently disabled each year.
A common neurological deficit among stroke survivors, and thus a substantial contributor to post-stroke disability, is aphasia. The loss of, or difficulty with language is extremely debilitating and has enormous social and economic impact on quality of life. Presently, the only treatment available for persons with aphasia is speech-language rehabilitation.
With rehabilitation only, however, many patients achieve a less than satisfactory improvement in speech-language function, and thus are left with significant disability.
Enhancing stroke recovery by facilitating brain plasticity with the direct application of stimulation to the cerebral cortex is a new area of investigation and shows promise for improving language recovery in stroke-induced aphasia, most probably when it is combined with intense learning. There are several methods of delivering cortical brain stimulation to modulate cortical excitability, each of which have been studied in animal models with promising results, and subsequently applied to the rehabilitation of motor deficits after stroke. Applications to language problems after stroke are only emerging. Nevertheless, results suggest a potential role for cortical stimulation as an adjuvant strategy in aphasia rehabilitation.
Of the cortical stimulation methods available, transcranial direct current stimulation (tDCS) has the greatest potential for clinical use in view of its non-invasive application, ease of administration and relatively low cost. tDCS is a method of delivering weak polarizing electrical currents to the cortex via two electrodes placed on the scalp. The nature of the effect depends on the polarity of the current. Anodal tDCS has an excitatory effect; cathodal tDCS induces inhibition.
This study proposes to evaluate the safety, feasibility, and effectiveness of anodal and cathodal tDCS in study subjects with Broca's aphasia after stroke, delivered concurrent with speech-language rehabilitation.
Subjects will receive speech and language therapy combined with either anodal, cathodal, or sham stimulation applied to the lesioned left hemisphere. The polarity conditions will be compared with each other and with sham stimulation, to determine safety, the degree to which improvements in language performance occur, and the degree to which they are maintained over time.
The protocol is single-blind. Neither the subjects nor the outcomes assessor will know what stimulation the subject received until the study's conclusion; the investigator applying the stimulation will know.
Study Type
Enrollment (Anticipated)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Center for Aphasia Research & Treatment, Rehabilitation Institute of Chicago
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A single unilateral left-hemisphere infarct that is confirmed by CT scan or MRI
- Nonfluent aphasia, with a mean length of utterance of 0-4 words and an Aphasia Quotient score on the Western Aphasia Battery of 25-70
- Age 21 or older
- At least 6 months post-stroke
- Premorbidly right-handed, as determined by the Edinburgh Handedness Inventory
- Premorbidly literate in English
- Completed at least an eighth grade education
- Visual acuity no worse than 20/100 corrected in the better eye
- Auditory acuity, aided in the better ear, no worse than 30 dB HL on a pure tone hearing screening (conducted at 500, 1000, 2000, and 4000 Hz.)
Exclusion Criteria:
- Any other neurological condition (other than cerebral vascular disease) that could potentially affect cognition or speech, such as Parkinson's Disease, Alzheimer's Dementia, traumatic brain injury
- Any significant psychiatric history prior to the stroke, such as severe major depression or psychotic disorder requiring hospitalization; subjects with mood disorders who are currently stable on treatment will be considered
- Active substance abuse
- Seizure disorder that precludes safe participation in this trial
- Absence of left hemisphere activation during two of the three fMRI tasks
- Presence of lesions that encompass premotor cortex from the Sylvian fissure to a point high on the convexity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Anodal stimulation
|
Anodal transcranial direct stimulation (tDCS) to the left hemisphere, 1.0 mA for 13 minutes, is received five days a week, for six weeks, during the initial 13 minutes of 90 minutes of speech-language treatment.
Other Names:
|
ACTIVE_COMPARATOR: Cathodal stimulation
|
Cathodal transcranial direct stimulation (tDCS) to the left hemisphere, 1.0 mA for 13 minutes, is received five days a week, for six weeks, during the initial 13 minutes of 90 minutes of speech-language treatment.
Other Names:
|
PLACEBO_COMPARATOR: Sham stimulation
|
Sham stimulation provided together with 90 minutes of speech language therapy, 5 days a week, for 6 weeks.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Aphasia Quotient (AQ) on the Western Aphasia Battery
Time Frame: Change from Baseline in Western Aphasia Battery at 6 weeks
|
Change from Baseline in Western Aphasia Battery at 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Western Aphasia Battery Aphasia Quotient (Maintenance)
Time Frame: Change in Western Aphasia Battery AQ from 6 weeks to 12 weeks
|
Change in Western Aphasia Battery AQ from 6 weeks to 12 weeks
|
|
Western Aphasia Battery Reading and Writing Scores (Maintenance)
Time Frame: Change in WAB Reading and Writing Skills from 6 weeks to 12 weeks
|
Change in WAB Reading and Writing Skills from 6 weeks to 12 weeks
|
|
Functional communication skills
Time Frame: Change from Baseline in functional communication skills at 6 weeks
|
Scores derived from language sample analyses
|
Change from Baseline in functional communication skills at 6 weeks
|
Participation in everyday activities
Time Frame: Change from Baseline in participation in everyday activities at 6 weeks
|
Measures on CETI, BOSS, CCRSA
|
Change from Baseline in participation in everyday activities at 6 weeks
|
Western Aphasia Battery - Reading and Writing scores
Time Frame: Change from Baseline in Western Aphasia Battery Reading and Writing scores at 6 weeks
|
Change from Baseline in Western Aphasia Battery Reading and Writing scores at 6 weeks
|
|
Functional Communication Skills (Maintenance)
Time Frame: Communication skills from 6 weeks to 12 weeks
|
Communication skills from 6 weeks to 12 weeks
|
|
Participation in everyday activities (Maintenance)
Time Frame: Change in participation in everyday activities from 6 weeks to 12 weeks
|
Change in participation in everyday activities from 6 weeks to 12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Leora R Cherney, PhD, Rehabilitation Institute of Chicago, Chicago, IL
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-kaye
- 1R21DC009876-01A1 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Transcranial Direct Current Stimulation - Anodal stimulation
-
Dina Hatem ElhammadyUnknown
-
Texas Woman's UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruiting
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedFrontotemporal Dementia | GRN Related Frontotemporal DementiaItaly
-
Federal University of ParaíbaCompleted
-
Karthick BalasubramanianNot yet recruitingStroke | Stroke, IschemicSaudi Arabia
-
National Taiwan University HospitalNational Science and Technology CouncilCompletedTranscranial Direct Current StimulationTaiwan
-
University of CalgaryCompleted
-
University of CalgaryCompletedLaparoscopic Surgical ProceduresCanada
-
University Hospital TuebingenGerman Federal Ministry of Education and Research; Universität TübingenUnknownMajor Depression | Emotion Regulation | Anodal Stimulation tDCS | Cognitive ControlGermany
-
5 SantéCompleted